Moberg Pharma's Terclara fails Phase 3 trial for fungal nail infection maintenance dosing; Bayer exits partnership and ...

The first three-way fungicide co-formulation containing Iblon (isoflucypram) has gained approval for use in cereals, offering ...

UBS analyst Geoff Haire maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The company’s shares ...

Bayer has received regulatory authorisation for Plaxium, its first three-way formulation fungicide containing Iblon (isoflucypram). The news means Plaxium will be available to growers for use across a ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) on December 3 and set a price target of €25.00.

Dhanuka Agritech Ltd. is aiming to clock 18% growth in revenue and 20% increase in volume in fiscal 2025 on an aggregate ...